# Clinical Pathology: Hematology and Biochemistry Interpretation ## Key Takeaways - Reference intervals are critical for interpretation and must be species, age, sex, and laboratory-specific; adopting manufacturer or literature intervals without local validation risks misclassification of healthy patients. - Anemia classification hinges on the reticulocyte response (regenerative vs. non-regenerative), with corrected reticulocyte percentage or absolute count being essential for assessing marrow output, not uncorrected percentages in anemic patients. - Preanalytical errors such as hemolysis, lipemia, and improper anticoagulant use are common and can significantly alter results; visual inspection of sample quality and understanding anticoagulant effects (e.g., EDTA in horses) are crucial. - Liver enzyme interpretation requires distinguishing hepatocellular injury (ALT, AST) from cholestasis (ALP, GGT), and AST is not liver-specific in many species, necessitating pairing with muscle enzyme assessment (CK). - Renal function assessment combines BUN, creatinine, and urine specific gravity, with urine specific gravity being vital for differentiating prerenal azotemia from renal azotemia; BUN is less specific due to influences of protein intake and hydration. - Serial clinical pathology testing is essential for monitoring disease progression and treatment efficacy, with appropriate parameter selection (e.g., PCV for red cell mass, reticulocyte count for marrow response) and understanding the lag time between pathologic events and detectable laboratory changes. --- Clinical pathology is the discipline that translates laboratory measurements into physiological and pathological insight. For the veterinary student, the complete blood count and serum biochemistry panel are the most frequently requested diagnostic tools in practice, yet their interpretation demands more than pattern recognition. This article provides a structured framework for interpreting common hematology and biochemistry results across species, with emphasis on the diagnostic reasoning that connects laboratory findings to pathophysiologic mechanisms. It is written for veterinary students who understand clinical terminology and are building their interpretive skills, and it deliberately excludes advanced diagnostics and disease-specific deep dives. The central question this article answers is straightforward: when a laboratory report arrives, how does the clinician decide which abnormalities matter, which are artifacts, and which point toward a specific category of disease? The answer lies in understanding biological variability, preanalytical error, and the physiologic logic that links each analyte to organ function or cellular turnover. This foundation supports the practical interpretive algorithms presented in later sections of this article. ## At a Glance | Parameter | Key Decision | Common Pitfall | | --- | --- | --- | | Reference intervals | Compare to species, age, sex, and laboratory-specific values | Adopting manufacturer or literature intervals without local validation | | Hematocrit / PCV | Classify anemia as regenerative or non-regenerative before pursuing etiology | Ignoring hemoconcentration or hemodilution from sample handling | | Reticulocyte count | Use corrected reticulocyte percentage or absolute count to assess marrow response | Relying on uncorrected percentages in severely anemic patients | | Total protein | Pair with albumin and globulins to distinguish hemorrhage, inflammation, and liver disease | Interpreting total protein alone without fractionation | | ALT and AST | Localize enzyme elevations to hepatocellular injury versus muscle damage | Forgetting that AST is not liver-specific in many species | | BUN and creatinine | Assess prerenal, renal, and postrenal contributions using urine specific gravity | Assuming both rise equally in all renal disease | | Glucose | Confirm hyperglycemia with repeat measurement and consider stress versus diabetes mellitus | Overinterpreting a single mildly elevated value in cats | | Calcium | Correct for albumin and interpret with phosphorus and PTH status | Missing ionized hypocalcemia when total calcium is normal | ## The Biological Basis of Reference Intervals Reference intervals are the interpretive foundation of every laboratory result. They are generated from a healthy reference population and typically encompass the central 95% of values, meaning that 5% of healthy individuals will fall outside the interval by chance alone. This statistical reality explains why a single mildly abnormal value in an otherwise stable patient often warrants repeat testing instead of immediate diagnostic action. Species, breed, age, sex, and reproductive status all shift reference intervals. A greyhound's hematocrit exceeds that of most other breeds, while a neonatal foal's creatinine is elevated relative to adult norms for the first days of life. Laboratory-specific intervals are always preferred over published values because analytic methods and instrumentation vary. A survey of Swiss veterinary practices found that most clinics adopted reference intervals from manufacturers or literature instead of validating them locally, a practice that risks misclassification of healthy patients as diseased [Swiss veterinary point-of-care laboratory quality management survey](https://pubmed.ncbi.nlm.nih.gov/32146436/). When a result falls just outside the interval, the clinician should ask whether the patient resembles the reference population before assigning clinical significance. Biological variability also operates within an individual over time. Longitudinal data from healthy beagle dogs with chronic indwelling telemetry devices showed that routine hematology and chemistry endpoints fluctuated within expected biological ranges over three years, with no values that would have prevented study assignment [background variability in clinical pathology biomarkers in telemetered beagle dogs](https://pubmed.ncbi.nlm.nih.gov/24508734/). This finding underscores that minor fluctuations between serial samples are normal and should not be overinterpreted as progressive disease. ## Preanalytical and Analytical Error Laboratory error is most often preanalytical, occurring before the sample reaches the analyzer. Hemolysis, lipemia, and icterus interfere with spectrophotometric assays and can elevate or depress measured values unpredictably. Hemolysis falsely elevates potassium, magnesium, and AST while falsely lowering sodium and chloride in some analyzers. Lipemia interferes with nearly all colorimetric assays and can be reduced by fasting the patient or ultracentrifuging the sample. Sample collection site matters as well: venous samples differ from capillary samples, and prolonged tourniquet application can falsely elevate protein and calcium through hemoconcentration. Anticoagulant errors are common and consequential. EDTA is the standard for hematology because it preserves cell morphology, but it causes hemolysis in some species, notably horses and camelids, where heparin or citrate may be preferred. Clotted samples in EDTA tubes produce spurious thrombocytopenia and leukopenia. Serum biochemistry requires a clot activator tube, and using heparinized plasma for assays validated on serum can alter results for some analytes. Point-of-care analyzers introduce additional variability. The same Swiss survey found that internal quality control was performed by most practices, but participation in external quality assessment programs was rare, and comparative testing was more common than formal proficiency testing [Swiss veterinary point-of-care laboratory quality management survey](https://pubmed.ncbi.nlm.nih.gov/32146436/). Clinicians should know which analyzer produced a result and whether that analyzer has been validated for the species being tested. A chemistry value from a benchtop analyzer and the same value from a point-of-care device are not interchangeable, and serial monitoring should use the same instrument whenever possible. ## Hematology: The Complete Blood Count as a Physiologic Readout The complete blood count quantifies three cell lines: erythrocytes, leukocytes, and thrombocytes. Each lineage responds to disease in predictable patterns that form the basis of interpretive algorithms. The erythron reflects oxygen-carrying capacity and marrow production. The leukon reflects inflammation, infection, stress, and immune activation. The thrombocyte count reflects production, consumption, and destruction. Anemia classification begins with the marrow response. A regenerative anemia shows polychromasia, reticulocytosis, and often macrocytosis, indicating that the marrow is responding to blood loss or hemolysis. A non-regenerative anemia lacks these findings and points toward marrow suppression, chronic disease, or early-stage disease before the marrow has mounted a response. The reticulocyte count must be corrected for the degree of anemia, because the percentage of reticulocytes rises simply because total red cell numbers fall. The absolute reticulocyte count or the corrected reticulocyte percentage provides a more accurate assessment of marrow output. Leukocyte interpretation follows a similar logic. Neutrophilia with a left shift indicates an active inflammatory or infectious process. Neutropenia with a left shift suggests overwhelming consumption or marrow suppression. Lymphopenia is a common stress response mediated by endogenous corticosteroids, while lymphocytosis in young animals may be physiologic. Eosinophilia suggests parasitism or hypersensitivity, and monocytosis accompanies chronic inflammation or tissue necrosis. ## Biochemistry: Organ Systems and Metabolic Pathways Serum biochemistry panels are organized around organ systems, but the clinician must think in terms of pathophysiology instead of analyte lists. Hepatic enzymes fall into two categories: those that indicate hepatocellular injury, such as ALT and AST, and those that indicate cholestasis, such as ALP and GGT. Elevations in both categories suggest mixed hepatic disease, while isolated ALP elevation in a young, growing animal may be physiologic due to bone remodeling. Renal function is assessed through BUN, creatinine, and urine specific gravity. BUN is influenced by protein intake, hepatic function, and hydration status, making it less specific than creatinine. Creatinine is more specific but still rises with muscle mass and can be falsely lowered in cachectic patients. Neither analyte rises above the reference interval until approximately 75% of nephron mass is lost, so normal values do not exclude early renal disease. Urine specific gravity is essential for distinguishing prerenal azotemia from renal azotemia. Pancreatic and muscular enzymes require species-specific interpretation. Amylase and lipase are poorly sensitive and specific for pancreatitis in dogs and are unreliable in cats. Creatine kinase is muscle-specific and rises with muscle damage, exertion, or intramuscular injection, and it can confound AST interpretation when both are elevated. The clinician should always pair muscle enzymes with hepatic enzymes before attributing an elevated AST to liver disease. ## Integrating the Panel: Pattern Recognition and Diagnostic Reasoning The complete blood count and biochemistry panel are most powerful when interpreted together. A low hematocrit with normal total protein suggests hemolysis or chronic disease, while a low hematocrit with low total protein suggests blood loss. An elevated BUN with a low hematocrit and normal creatinine can indicate gastrointestinal bleeding, where digested blood is absorbed as urea. Hypercalcemia with a low phosphorus suggests humoral hypercalcemia of malignancy, while hypercalcemia with hyperphosphatemia points toward renal failure or hypoparathyroidism. Pattern recognition accelerates diagnosis, but it must be anchored in the individual patient's signalment, history, and physical examination. Laboratory results are never interpreted in isolation. The framework presented here prepares the student to approach any laboratory report systematically, and the subsequent sections of this article will apply these principles to specific interpretive algorithms and clinical scenarios. ## The Anemia Decision Tree Anemia is not a diagnosis. It is a laboratory finding that narrows the differential list and directs the next diagnostic step. The complete blood count provides three pieces of information that drive the decision tree: the magnitude of the red cell mass reduction, the regenerative response, and the red cell indices. ### Step 1: Confirm and Characterize Confirm that the anemia is real before pursuing it. A dehydrated patient can have a normal packed cell volume despite substantial red cell loss. Recheck the sample for clot formation, and interpret the packed cell volume against the total protein. A low packed cell volume with a normal or high total protein suggests a red cell production problem or acute blood loss with hemoconcentration. A low packed cell volume with a low total protein points toward hemorrhage or a protein-losing state. The reticulocyte count is the single most informative test in anemia classification. An absolute reticulocyte count above 60,000 per microlitre in dogs and above 50,000 per microlitre in cats indicates regeneration. In horses and ruminants, the reticulocyte response is slower and less pronounced, and the bone marrow response is better assessed by serial packed cell volume measurements over several days. ### Step 2: Classify by Regenerative Response **Regenerative anemia** indicates blood loss or hemolysis. The red cell indices help separate these two mechanisms. A regenerative anemia with normal red cell morphology and no hyperbilirubinaemia favours hemorrhage. A regenerative anemia with spherocytes, schistocytes, or Heinz bodies favours hemolysis. The presence of icterus without bilirubinuria in a dog with regenerative anemia strongly supports hemolysis. **Non-regenerative anemia** indicates a production problem. The reticulocyte count is low for the degree of anemia. The next decision point is whether the bone marrow failure is primary or secondary. A low packed cell volume with normal white blood cell and platelet counts points toward a pure red cell aplasia or an early inflammatory or renal cause. A pancytopenia with non-regenerative anemia suggests bone marrow disease and warrants bone marrow evaluation. ### Step 3: Route by Species and Signalment The decision tree branches by species. In cats, a non-regenerative anemia with macrocytosis raises the possibility of feline leukemia virus infection. In dogs, a regenerative anemia with spherocytes and a positive direct Coombs test supports immune-mediated hemolytic anemia. In horses, a non-regenerative anemia with low serum iron and normal total iron binding capacity suggests anemia of inflammatory disease. In ruminants, the most common cause of significant blood loss is internal parasitism, and fecal examination is a logical early step. | Anemia Category | Reticulocyte Response | Primary Differentials | Next Diagnostic Step | |---|---|---|---| | Regenerative, hemolytic | Increased | Immune-mediated, infectious, oxidative, inherited | Blood smear review, Coombs test, species-specific infectious disease testing | | Regenerative, hemorrhagic | Increased | Trauma, coagulopathy, gastrointestinal loss, parasitism | Coagulation panel, fecal examination, imaging for body cavity hemorrhage | | Non-regenerative, inflammatory | Normal or low | Chronic disease, renal disease, endocrine disease | Serum biochemistry, urinalysis, endocrine testing | | Non-regenerative, marrow failure | Low or absent | Drug toxicity, neoplasia, aplastic anemia, pure red cell aplasia | Bone marrow aspirate and core biopsy | The blood smear review is mandatory in every anemic patient. It provides morphologic information that automated analyzers cannot reliably report, including spherocytes, schistocytes, Heinz bodies, and nucleated red blood cells. The [Davis-Thompson Foundation veterinary pathology resources](https://www.davisthompsonfoundation.org/) offer structured case material for developing these morphologic interpretation skills. ## Biochemistry Abnormalities and Their Differentials Biochemistry panels generate a list of abnormalities. The diagnostic task is to determine which abnormalities are primary, which are secondary, and which are artefactual. The pattern of abnormalities matters more than any single value. ### Liver Enzyme Patterns The distinction between hepatocellular injury and cholestasis guides the interpretation of liver enzymes. A marked increase in alanine aminotransferase with a mild increase in alkaline phosphatase indicates hepatocellular damage. A marked increase in alkaline phosphatase with a mild increase in alanine aminotransferase indicates cholestasis. In dogs, corticosteroid-induced alkaline phosphatase is a common cause of isolated alkaline phosphatase elevation. In horses, alkaline phosphatase is less liver-specific, and gamma-glutamyl transferase is the preferred cholestatic marker. ### Renal and Electrolyte Patterns Azotaemia requires separation into prerenal, renal, and postrenal causes. The urine specific gravity is the critical test. A urine specific gravity above 1.030 in a dog or 1.035 in a cat with azotaemia indicates prerenal azotaemia. A urine specific gravity in the isosthenuric range with azotaemia indicates renal disease. The [MSD Veterinary Manual professional edition](https://www.msdvetmanual.com/) provides species-specific reference intervals and interpretive guidance for these patterns. Electrolyte abnormalities often cluster. Hyponatraemia with hyperkalemia in a dog or cat raises the question of hypoadrenocorticism, particularly when accompanied by a low sodium to potassium ratio. Hypercalcemia with azotaemia requires differentiation between primary hyperparathyroidism, malignancy-associated hypercalcemia, and chronic kidney disease. The direction of change in phosphorus and the presence of hypercalciuria help separate these possibilities. ### Protein Patterns Total protein is the sum of albumin and globulins. A low albumin with normal globulins suggests a protein-losing state or decreased production. A high globulin with normal albumin suggests inflammation or neoplasia. Serum protein electrophoresis separates the globulin fractions and can distinguish a polyclonal gammopathy from a monoclonal gammopathy. The latter raises concern for multiple myeloma or other B-cell neoplasia. ## Point-of-Care Versus Reference Laboratory Testing The choice between point-of-care and reference laboratory testing changes the interpretive framework. Point-of-care analyzers are widely used in veterinary practice, with one survey reporting that 69% of participating Swiss practices had automated point-of-care analyzers, mainly for clinical chemistry and hematology [Swiss veterinary point-of-care laboratory survey](https://pubmed.ncbi.nlm.nih.gov/32146436/). The same survey found that reference intervals were adopted from manufacturers in 80% of practices, and only a minority participated in external quality assessment programs. These findings carry practical implications. Manufacturer-derived reference intervals may not match the patient population or the local laboratory methods. Internal quality control performed once monthly or less frequently may not detect analyzer drift. When a point-of-care result does not fit the clinical picture, repeat the sample on a reference laboratory analyzer before acting on the result. The decision to use point-of-care or reference laboratory testing depends on patient stability, the urgency of the clinical question, and the equipment available. A collapsed dog with suspected hemolytic anemia needs an immediate packed cell volume and blood smear. A stable cat with chronic weight loss and a mild anemia can wait for a full reference laboratory panel with reticulocyte count and biochemistry. ## Monitoring Parameters and Serial Assessment Serial clinical pathology testing detects trends that a single sample cannot. The [background variability study in telemetered beagle dogs](https://pubmed.ncbi.nlm.nih.gov/24508734/) demonstrated that routine hematology and clinical chemistry endpoints remained within expected biological variability over three years of repeated sampling. This finding supports the use of serial testing to monitor chronic disease, provided the reference intervals are appropriate for the species and the laboratory methods. Monitoring intervals depend on the disease process and the treatment. A patient receiving immunosuppressive doses of glucocorticoids for immune-mediated hemolytic anemia requires weekly packed cell volume and platelet counts during the induction phase. A patient with chronic kidney disease requires biochemistry and urinalysis every two to three months, with more frequent testing when the creatinine or phosphorus is rising. A patient on long-term anticonvulsant therapy requires liver enzyme monitoring every six months. The monitoring parameter must match the question. Packed cell volume detects red cell mass changes. Reticulocyte count detects bone marrow response. Platelet count detects thrombocytopenia. Serum creatinine detects glomerular filtration changes. Each parameter has a lag time between the pathologic event and the detectable laboratory change, and the clinician must account for this lag when interpreting serial results. ## Documentation and Communication of Laboratory Findings The laboratory report is a medical record document. It must include the patient identification, the sample type and collection time, the analyzer and method used, the results with reference intervals, and any quality control issues. When a result is outside the reference interval, the clinician should record the interpretation and the planned action. Communication of laboratory findings to the owner requires translation of the numeric results into clinical meaning. The owner needs to understand what the test result means for the pet's condition, what further testing is recommended, and what the monitoring plan will be. The [AVMA practice resources](https://www.avma.org/resources-tools) provide guidance on professional communication and medical record standards. Documentation also serves a quality assurance function. If a laboratory result is later questioned, the record must show what was done, when it was done, and why. This is particularly relevant when point-of-care results are used to make treatment decisions, because the [Swiss survey of point-of-care laboratories](https://pubmed.ncbi.nlm.nih.gov/32146436/) found that quality management practices vary considerably between practices. ## Recognized Failure Modes and Early Detection Laboratory interpretation fails in predictable ways. The most consequential is the uncritical acceptance of a single abnormal value as diagnostic. Every analyte carries inherent biologic variability, and serial sampling in clinically stable animals can show fluctuations that fall outside the expected range without indicating disease. Longitudinal data from chronically instrumented beagle dogs demonstrate that routine hematology and chemistry endpoints remain consistent over years, but occasional values may trend or fluctuate while still representing normal biology instead of pathology. The discriminating check is repetition: confirm a surprising result on a fresh sample before committing to a diagnostic plan. A second failure mode is the reference interval mismatch. Point-of-care analyzers frequently use manufacturer-derived intervals that may not match the instrument's current calibration or the local patient population. Survey data from Swiss veterinary practices show that most clinics adopt manufacturer reference intervals and run internal quality control only monthly or less often, with few participating in external quality assessment programs. When an analyte falls marginally outside the interval, ask whether the interval was verified for the specific analyzer and species before interpreting the result as abnormal. Hemolysis, lipemia, and icterus constitute a third failure mode. These interfere with spectrophotometric assays and can produce spurious hyperkalemia, hypoproteinemia, or elevated liver enzyme activities. Early detection requires a standardized practice: record sample quality at collection, inspect the serum or plasma visually before analysis, and flag results from visibly hemolysed or lipaemic samples for cautious interpretation or repeat collection. | Observation | Likely Cause | Discriminating Check | |---|---|---| | Isolated mild hyperkalemia, normal ECG | Hemolysis or delayed serum separation | Repeat on heparinised plasma, inspect sample color | | Elevated ALT with normal bile acids and no clinical signs | Lipemia or recent feeding | Repeat after 12 h fast, check sample turbidity | | Single low hematocrit in a stable patient | Sampling dilution or biologic variation | Repeat CBC, assess reticulocyte count | | Result outside reference interval but clinically implausible | Unverified reference interval or calibration drift | Run quality control material, verify interval source | ## Common Errors in Interpretation Less experienced clinicians often over-interpret minor deviations. A single analyte outside the reference interval, particularly when the magnitude is small, rarely establishes a diagnosis. The corrective action is pattern-based reasoning: ask whether the abnormality fits a coherent physiologic or pathologic theme with the rest of the panel, the physical examination, and the signalment. An isolated mild increase in creatine kinase without muscle signs, pigmenturia, or recent exertion is more likely artefact or sampling trauma than myopathy. A second recurring error is the failure to account for species and age. Ruminants and horses have different leukocyte biology than dogs and cats, and neonatal animals show distinct hematologic profiles. The corrective action is to consult species-specific reference material before interpreting any panel, particularly for species where published intervals are limited. A third error is treating the laboratory report as the diagnosis instead of a test of a hypothesis. The complete blood count and biochemistry panel refine a differential list, they do not replace the history and physical examination. When the laboratory result contradicts the clinical picture, the correct response is to question the laboratory result, not the patient. ## Limitations of Evidence and Divergent Expert Opinion The evidence base for clinical pathology interpretation rests heavily on data from purpose-bred research animals and laboratory species. Studies evaluating the safety of genetically modified feed grains in rats, for example, report that clinical pathology parameters remained comparable between treatment and control groups across multiple feeding trials. These data support the stability of standard analytes under controlled conditions, but they do not address the variability seen in clinical patients with concurrent disease, medication, or subclinical inflammation. Extrapolation from research colonies to clinical populations requires caution. Expert opinion still differs on several points. The clinical significance of mild, isolated enzyme elevations without histopathologic confirmation remains contested. The utility of routine coagulation testing in preoperative screening is debated across species. The frequency with which reference intervals should be revalidated, and the minimum number of animals required for interval establishment, are not standardized across laboratories or jurisdictions. Where published guidance is absent, the clinician should document the reasoning behind the interpretive choice and revisit it if the clinical course diverges from expectation. ## Escalation and Referral Referral to a specialist or diagnostic laboratory is warranted when the pattern is ambiguous, the condition is deteriorating despite treatment, or the diagnostic question exceeds the capacity of in-house testing. Specific triggers include: progressive anemia that does not respond to initial classification, unexplained pancytopenia, persistent electrolyte disturbances that resist correction, and suspected immune-mediated or neoplastic disease requiring flow cytometry, cytogenetics, or bone marrow evaluation. The Davis-Thompson Foundation maintains diagnostic pathology teaching resources and case material that can support structured review of difficult cases, and the MSD Veterinary Manual provides species-specific guidance for interpreting complex panels in clinical context. Laboratory involvement is appropriate when quality control failures are suspected, when results are implausible, or when a reference interval appears inappropriate for the instrument. External quality assessment participation, though uncommon in some regions, provides the only reliable check on inter-laboratory comparability. Regulatory reporting obligations vary by jurisdiction and species. Reportable diseases, particularly those with trade implications, may require notification to the relevant animal health authority. The World Organization for Animal Health terrestrial animal health standards describe the framework for disease notification and surveillance, and the American Veterinary Medical Association provides practice resources for US-based reporting obligations. The clinician should know the reportable disease list for the practice jurisdiction before a suspicious result appears, not after. When in doubt about whether a finding is reportable, contact the local veterinary authority directly. ## Frequently Asked Questions ### How Should I Prioritize Testing When the Practice Has Limited Laboratory Resources? When a full panel is not feasible, prioritize tests that answer the immediate diagnostic question. For an anemic patient, a packed cell volume, total protein, and blood smear review outperform a full biochemistry panel. For suspected hepatopathy, start with alanine aminotransferase, alkaline phosphatase, bilirubin, and fasting bile acids. In-house analyzers vary widely in capability, and a survey of Swiss veterinary practices found that most adopted manufacturer reference intervals instead of validating their own, which can misclassify results in certain patient populations [Swiss veterinary point-of-care laboratory survey](https://pubmed.ncbi.nlm.nih.gov/32146436/). When in doubt, run the minimum tests that distinguish the leading differentials, then submit remaining samples to a reference laboratory. ### What Do I Do When a Result Falls Just Outside the Reference Interval? A marginal abnormality is not a diagnosis. First, confirm the value was not affected by hemolysis, lipemia, or prolonged sample storage. Second, consider the magnitude of change relative to biological variability. Serial monitoring in healthy beagle dogs showed that routine hematology and chemistry endpoints fluctuate within expected biological ranges over months, and isolated excursions do not necessarily indicate disease [background variability in clinical pathology biomarkers in telemetered beagles](https://pubmed.ncbi.nlm.nih.gov/24508734/). Recheck the analyte in 24 to 72 hours if the patient is stable. If the abnormality persists, expands, or is accompanied by clinical signs, pursue it further. A single marginal elevation rarely justifies aggressive intervention. ### How Do I Interpret Panels in Species With Poorly Established Reference Intervals? For exotic, avian, or wildlife patients, published reference intervals may be absent or derived from small sample sizes. Interpret results using species-specific resources such as the [MSD Veterinary Manual](https://www.msdvetmanual.com/) and compare against the patient's own serial values whenever possible. A single measurement is less informative than a trend. For herd animals, sample multiple individuals and interpret group patterns instead of individual outliers. Be explicit in the medical record that the reference interval used is provisional. When the clinical picture conflicts with laboratory findings, trust the physical examination and pursue confirmatory testing before committing to a diagnosis. ### How Should I Document Laboratory Results to Support Clinical Decision-Making? Record the analyzer used, sample quality, and any preanalytical issues alongside the numerical results. Note whether the sample was run in-house or at a reference laboratory, as methods differ. Include the reference interval applicable to that analyzer and species. Document your interpretation, also the numbers, including which differentials the results support or exclude. If results are communicated to a client or referring veterinarian, record the date, time, and content of that conversation. The [AVMA practice resources](https://www.avma.org/resources-tools) provide guidance on medical record standards that support continuity of care and defensible decision-making. ### How Do I Explain Conflicting Laboratory and Clinical Findings to a Client? Acknowledge the discrepancy directly and explain that laboratory results are one component of the diagnostic picture. Use an analogy such as a smoke alarm: it can sound without visible fire, and fire can exist before the alarm triggers. Explain that repeat testing, additional samples, or different tests may clarify the situation. Avoid overstating the certainty of any single result. If you recommend further testing, state what specific question the next test will answer and what the result will change. This approach maintains client trust while keeping the diagnostic process transparent and honest. ### When Should I Repeat a Test Versus Pursue Advanced Diagnostics? Repeat a test when preanalytical error is suspected, the result is marginal, or the patient's clinical status has changed. Pursue advanced diagnostics when a pattern of abnormalities points to a specific organ system and the diagnosis remains uncertain, or when the treatment implications are substantial. For example, persistent hypercalcemia with a normal albumin warrants ionized calcium measurement and further staging before symptomatic therapy. Serial monitoring is appropriate for chronic conditions where trends guide therapy adjustments. The [Davis-Thompson Foundation pathology resources](https://www.davisthompsonfoundation.org/) offer case-based material that can help build confidence in deciding when laboratory findings justify escalation to histopathology or specialized testing. ## Related Clinical & Scientific Guides * [Hypersensitivity Reactions: Types and Mechanisms](/knowledge/veterinary-medicine/veterinary-pathology-microbiology/hypersensitivity-reactions-types-and-mechanisms) * [Therapeutic Decision-Making for Respiratory Infections in Cattle](/knowledge/veterinary-medicine/veterinary-pathology-microbiology/therapeutic-decision-making-respiratory-infections-cattle) * [Monitoring Fluid Therapy in Critically Ill Veterinary Patients](/knowledge/veterinary-medicine/veterinary-pathology-microbiology/monitoring-fluid-therapy-critically-ill-veterinary) ## References and Further Reading - [Background variability in standard clinical pathology biomarkers in beagle dogs instrumented with chronic indwelling telemetry devices.](https://pubmed.ncbi.nlm.nih.gov/24508734/). 2014. - [Results of a 13 week safety assurance study with rats fed grain from glyphosate tolerant corn.](https://pubmed.ncbi.nlm.nih.gov/15110110/). 2004. - [Results of a 90-day safety assurance study with rats fed grain from corn borer-protected corn.](https://pubmed.ncbi.nlm.nih.gov/16487643/). 2006. - [Results of a 90-day safety assurance study with rats fed grain from corn rootworm-protected corn.](https://pubmed.ncbi.nlm.nih.gov/16084637/). 2006. - [Investigation of the Status Quo of Veterinary Point-of-Care Laboratories in Switzerland: Availability, Application, and Quality Management.](https://pubmed.ncbi.nlm.nih.gov/32146436/). 2020. - [Novel methods for the assessment of safety pharmacology and toxicology parameters in anesthetized and ventilated dogs receiving inhaled drugs.](https://pubmed.ncbi.nlm.nih.gov/31078712/). 2019. - [Davis-Thompson Foundation Veterinary Pathology Resources](https://www.davisthompsonfoundation.org/). Davis-Thompson Foundation. - [MSD Veterinary Manual, Professional Edition](https://www.msdvetmanual.com/). MSD Veterinary Manual. - [American Veterinary Medical Association Practice Resources](https://www.avma.org/resources-tools). American Veterinary Medical Association. ## Related Articles - [Diagnostic Cytology: Sample Collection and Interpretation](/knowledge/veterinary-medicine/veterinary-pathology-microbiology/diagnostic-cytology-sample-collection-and-interpretation) - [Differential Diagnosis in Pathology: A Structured Approach](/knowledge/veterinary-medicine/veterinary-pathology-microbiology/differential-diagnosis-in-pathology-a-structured-approach) - [Edema and Shock: Pathophysiologic Mechanisms](/knowledge/veterinary-medicine/veterinary-pathology-microbiology/edema-and-shock-pathophysiologic-mechanisms) - [Microscopy Skills for Veterinary Pathology: Brightfield to Fluorescence](/knowledge/veterinary-medicine/veterinary-pathology-microbiology/microscopy-skills-for-veterinary-pathology-brightfield-to-fluorescence) - [Thrombosis and Embolism: Pathophysiology and Consequences](/knowledge/veterinary-medicine/veterinary-pathology-microbiology/thrombosis-and-embolism-pathophysiology-and-consequences) > This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.